GR3017321T3 - Use of amino acids for the protection of and metabolic recovery of ischemic cardiac tissue. - Google Patents

Use of amino acids for the protection of and metabolic recovery of ischemic cardiac tissue.

Info

Publication number: GR3017321T3
Authority: GR; Greece
Prior art keywords: amino acids; protection; cardiac tissue; ischemic cardiac; metabolic recovery
Prior art date: 1990-10-30

Application number

GR950402450T

Other languages

English (en)

Inventor

David Madsen

Gary Pace

Bruce Rowe

Original Assignee

Clintec Nutrition Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-10-30

Filing date

1995-09-06

Publication date

1995-12-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24423981&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3017321(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-09-06 Application filed by Clintec Nutrition Co filed Critical Clintec Nutrition Co

1995-12-31 Publication of GR3017321T3 publication Critical patent/GR3017321T3/el

Links

150000001413 amino acids Chemical class 0.000 title abstract 3
210000005003 heart tissue Anatomy 0.000 title 1
230000000302 ischemic effect Effects 0.000 title 1
230000002503 metabolic effect Effects 0.000 title 1
238000011084 recovery Methods 0.000 title 1
208000028867 ischemia Diseases 0.000 abstract 3
230000000747 cardiac effect Effects 0.000 abstract 1
229940030602 cardiac therapy drug Drugs 0.000 abstract 1
230000004217 heart function Effects 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Organic Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Vascular Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GR950402450T 1990-10-30 1995-09-06 Use of amino acids for the protection of and metabolic recovery of ischemic cardiac tissue. GR3017321T3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US60551490A	1990-10-30	1990-10-30

Publications (1)

Publication Number	Publication Date
GR3017321T3 true GR3017321T3 (en)	1995-12-31

Family

ID=24423981

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR950402450T GR3017321T3 (en)	1990-10-30	1995-09-06	Use of amino acids for the protection of and metabolic recovery of ischemic cardiac tissue.

Country Status (9)

Country	Link
EP (1)	EP0483614B1 (el)
JP (1)	JPH04264024A (el)
AT (1)	ATE123941T1 (el)
AU (1)	AU655780B2 (el)
CA (1)	CA2054134A1 (el)
DE (1)	DE69110615T2 (el)
DK (1)	DK0483614T3 (el)
ES (1)	ES2074623T3 (el)
GR (1)	GR3017321T3 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5852058A (en) *	1993-06-11	1998-12-22	The Board Of Trustees Of The Leland Stanford Junior University	Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US5891459A (en)	1993-06-11	1999-04-06	The Board Of Trustees Of The Leland Stanford Junior University	Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
DE69637676D1 (de) *	1995-11-09	2008-10-23	Univ R	Verwendung von lokal verabreichten Lysine zur VERBESSERUNG DER VASKULAREN FUNKTION
US6127419A (en) *	1998-11-23	2000-10-03	Burzynski; Stanislaw R.	Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
IT1320782B1 (it) *	2000-07-04	2003-12-10	Professional Dietetics Srl	Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca.
US7238727B2 (en)	2000-10-13	2007-07-03	Chugai Seiyaku Kabushiki Kaisha	Compositions for improving lipid metabolism
ITTO20010580A1 (it) *	2001-06-15	2002-12-15	Professional Dietetics Srl	Composizioni a base di aminoacidi per il miglioramento della funzioneventricolare miocardica in pazienti affetti da diabete.
JP2008056566A (ja) *	2004-12-28	2008-03-13	Toudai Tlo Ltd	低酸素応答促進剤
US20170128412A1 (en) *	2015-08-11	2017-05-11	Satoru Sugiyama	System and method for improved blood circulation and maintaining mitochondrial energy production
JP6838752B2 (ja) *	2019-08-30	2021-03-03	株式会社東洋新薬	血流改善組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3228127A1 (de) *	1982-07-28	1984-02-02	Basf Ag, 6700 Ludwigshafen	Aminosaeuren-infusionsloesungen
WO1988001872A1 (en) *	1986-09-10	1988-03-24	Dudrick Medical Research Fund I, Ltd.	Method and substrate composition for treating atherosclerosis

1991
- 1991-10-08 AU AU85670/91A patent/AU655780B2/en not_active Ceased
- 1991-10-18 ES ES91117799T patent/ES2074623T3/es not_active Expired - Lifetime
- 1991-10-18 DK DK91117799.6T patent/DK0483614T3/da active
- 1991-10-18 DE DE69110615T patent/DE69110615T2/de not_active Revoked
- 1991-10-18 AT AT91117799T patent/ATE123941T1/de not_active IP Right Cessation
- 1991-10-18 EP EP91117799A patent/EP0483614B1/en not_active Revoked
- 1991-10-24 CA CA002054134A patent/CA2054134A1/en not_active Abandoned
- 1991-10-30 JP JP3284364A patent/JPH04264024A/ja active Pending
1995
- 1995-09-06 GR GR950402450T patent/GR3017321T3/el unknown

Also Published As

Publication number	Publication date
ATE123941T1 (de)	1995-07-15
CA2054134A1 (en)	1992-05-01
DK0483614T3 (da)	1995-10-30
ES2074623T3 (es)	1995-09-16
AU655780B2 (en)	1995-01-12
EP0483614B1 (en)	1995-06-21
JPH04264024A (ja)	1992-09-18
EP0483614A1 (en)	1992-05-06
DE69110615D1 (de)	1995-07-27
DE69110615T2 (de)	1995-12-14
AU8567091A (en)	1992-05-07

Publication	Publication Date	Title
US5091171B2 (en)	1997-07-15	Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
SE8703625D0 (sv)	1987-09-18	New medical use
IL76119A0 (en)	1985-12-31	Initiating reperfusion treatment when heart attack symptoms are present
EP0299756A3 (en)	1990-10-17	Anti-acne composition
DE69534468D1 (de)	2006-02-02	Wachstums-differenzierungsfaktor-11
IE791235L (en)	1979-12-27	Acyl-derivatives of carnitine.
DK0770089T3 (da)	2000-10-23	Vækstdifferentieringsfaktor-12
GR3017321T3 (en)	1995-12-31	Use of amino acids for the protection of and metabolic recovery of ischemic cardiac tissue.
NO865132D0 (no)	1986-12-17	Sulfat-forestrede peptider.
NO995944L (no)	2000-02-02	Anti-arrytmisk blanding og fremgangsmåter for behandling
GR3005362T3 (el)	1993-05-24
JPS56501648A (el)	1981-11-12
GR3006674T3 (el)	1993-06-30
ZA87466B (en)	1988-07-22	Heptanoyl-glu-asp-ala-amino acid immunostimulants
EP0196180A3 (en)	1989-11-29	A machine for providing electromagnetic pulses for therapeutic purposes
JPS51118547A (en)	1976-10-18	Facial treatment with intermittent direct current
Richardson	1988	Cognitive-behavioral therapy for the treatment of headaches diagnosed as common migraine a minimal-therapist-contact approach versus a clinic-based approach.
Ellison et al.	1983	Penetration of I super (125) labelled N. nigricollis venom in relationship to effects on the corneal erosion syndrome in albino and pigmented rabbits.
ZA882096B (en)	1989-12-27	Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2-(bipranole)and its acid addition salts for use as active therapeutic substances
AU7931487A (en)	1988-04-14	Therapeutic treatment of abnormal cell growth with follicle regulatory protein
EP0210099A3 (en)	1989-11-23	Use of n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamide in the treatment of parkinsons's disease